...
首页> 外文期刊>Experimental Gerontology >Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study.
【24h】

Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study.

机译:褪黑激素对围绝经期和绝经期妇女的影响:一项随机对照研究。

获取原文
获取原文并翻译 | 示例
           

摘要

In aging humans, night levels of melatonin (MEL) decline progressively. Also thyroid and gonadal functions decline during aging while gonadotropins (luteotropic hormone (LH) and follicle stimulating hormone (FSH)) steadily increase. A desynchronization of pineal circadian cyclicity as expressed by the progressive decrease of the MEL night peak may be permissively linked to the onset and progression of menopause. We studied the effects of exogenous, evening administration of MEL on the level of hormones which are known to be involved in the genesis and progression of menopause. Perimenopausal and menopausal women from 42 to 62years of age with no pathology or medication were selected. MEL was measured in saliva to divide them into low, medium and high-MEL patients. Half of them took 3mg MEL and half of them Placebo at bedtime (10-12p.m.) in a fully randomized and double-blind fashion. Three and six months later blood was taken for determination of pituitary (LH, FSH), ovarian, and thyroid hormones I(T3 and T4). All women taking MEL with low basal level of MEL and/or Placebo for three and six months showed a significant increase in levels of thyroid hormones. Before initiation of the study, a negative correlation was found in all women between LH, FSH and basal MEL levels. Within six months of treatment, MEL produced a significant diminution of LH in the younger women (43 to 49year-old), while no effect was seen in the older women (50-62years old). A decrement of FSH was observed in MEL-treated women with low basal MEL levels. In addition, most MEL-treated women reported a general improvement of mood and a significant mitigation of depression. MEL decline during aging may thus signal the derangement of pineal and pituitary-controlled ovarian cyclicity and the progressive quenching of fertility in women. These findings seem to show a recovery of pituitary and thyroid functions in MEL-treated women, towards a more juvenile pattern of regulation.
机译:在衰老的人类中,夜间褪黑激素(MEL)含量逐渐下降。甲状腺和性腺功能在衰老过程中也会下降,而促性腺激素(促尿激素(LH)和促卵泡激素(FSH))稳定增加。 MEL夜间峰值的逐渐减少所表示的松果体昼夜节律周期的失步可能与绝经的发生和发展有关。我们研究了外源性晚上服用MEL对激素水平的影响,已知激素水平与更年期的发生和发展有关。选择42岁至62岁,无病理或药物治疗的绝经和绝经妇女。测量唾液中的MEL,将其分为低,中和高MEL患者。他们中的一半在就寝时间(晚上10点至下午12点)以完全随机和双盲的方式服用了3mg MEL,其中一半服用了安慰剂。三,六个月后,抽取血液来测定垂体(LH,FSH),卵巢和甲状腺激素I(T3和T4)。所有服用最低MEL和/或安慰剂基础水平的MEL的妇女在三个月和六个月内甲状腺激素水平均显着增加。在开始研究之前,在所有女性中,LH,FSH和基础MEL水平之间均呈负相关。在治疗的六个月内,MEL在年轻女性(43至49岁)中使LH显着降低,而在老年女性(50-62岁)中未见效果。在低基础MEL水平的接受MEL治疗的女性中,观察到FSH降低。另外,大多数接受MEL治疗的女性的情绪总体得到改善,抑郁症状得到显着缓解。衰老过程中的MEL下降可能预示着女性的松果体和垂体控制的卵巢周期紊乱以及生育能力的逐步抑制。这些发现似乎表明,接受MEL治疗的妇女的垂体和甲状腺功能已恢复,朝着更年轻的调节方式发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号